• Versatile: able to treat multiple diseases
• Can be administered with or without other protease inhibitors 

• Densely packed CNT arrays allow for better bio-incorporation, prevention of  glial scarring, chronic inflammation, and neuronal cell loss
• Readily functionalized to promote neuronal growth and tissue-electrode adhesion, enhancing electrode performance and quality of read-out signals
• Inherent mechanical stiffness enhances the rigidity of adjacent CNTs preventing buckling as in other high-aspect probe systems.

• Alternative method for hypodermic needles
• Coating uniformity
• Spatial control on coating length

• Could provide substantial high value intermediates
• Enzymatic catalysis is more energy efficient, yields less (industrial type) waste than chemically based methods
• Higher level of precision than most chemical reactions

• Algorithm specifically prepared to search entire genomes to identify off-target cleavage sites and design optimal primers for TALENs and ZFNs
• Available as a simple, user-friendly web-based tool; no extraordinary bioinformatics or biochemical skill required
• Capable of analyzing TALEN and ZFN sequences targeting human, rat, mouse, zebrafish, arabidopsis, yeast, D melanogaster,

This technology can be used in the development of yeast-based syntheses of plant alkaloids, or any other biosynthetic pathway that uses 5-hydroxytryptohan or L-DOPA as precursors. It can be used for the synthesis of compound monoterpene indole alkaloids derived from strictosidine (e.g. quinine, camptothecin, ajmalicine, serpentine, vinblastine and vincristine) or benzylisoquinoline alkaloids derived from dopamine (e.g. berberine and morphine).

• Viable, cellular micro-environments requiring precise control are achieved using hydrogel microspheres with diameter sizes ranging from 10-1000 micrometers
• A protective, semi-permeable capsule encases the cells and biomolecules
• Release rates of encapsulated biomolecules or drugs are controlled by adjusting the polymer parameters used to fabricate hydrogel microspheres

• Cheaper and faster to manufacture- production only involves synthesis of ligands, nanoparticles, and nano-antibodies; it does not involve cell-lines or animal work
• More effective- better accumulation and penetration is achieved due to the nanoparticle design
• Better for patients- dosage to achieve therapeutic efficacy is reduced and can lower the price, duration, and frequency of treatment

• Inexpensive, rapid, adaptable, and reliable in vivo system for sequestering and packaging of iRNAs
• Flexible, for long or short, single-stranded or double-stranded iRNA of any sequence
• Efficiently delivers iRNA to biological targets; VLP-iRNAs are readily taken up by many cell types

• Enhance vaccine immunogenicity
• Prolong vaccine protection
• Reduce safety risks associated with pathogen-derived vaccine adjuvants

• First discovery of small-molecules binding to the central catalytic domain of NGly1
• Could be used to treat the inherited genetic disorder resulting from NGly1 deficiency

• Prevent various infections currently impacting patients due to bacteria formation on medical tubes.
• Solution that can be utilized with existing medical tubes.
• Does not leach any materials from the tubing surface.

• Accelerated wound healing and tissue regeneration through drug-eluting sutures
• Increased drug loading and sustained drug delivery due to the interconnected porosity feature of the sutures
• Release of cytokines, extracellular matrix proteins, anti-inflammatory, anti-microbial, and pain management drugs to injury site